Works matching IS 03407004 AND DT 2013 AND VI 62 AND IP 9
Results: 9
Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 9, p. 1533, doi. 10.1007/s00262-013-1451-5
- By:
- Publication type:
- Article
Vaccination of castration-resistant prostate cancer patients with TroVax (MVA-5T4) in combination with docetaxel: a randomized phase II trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 9, p. 1511, doi. 10.1007/s00262-013-1457-z
- By:
- Publication type:
- Article
Increased CD14HLA-DR myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 9, p. 1439, doi. 10.1007/s00262-013-1450-6
- By:
- Publication type:
- Article
Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 9, p. 1453, doi. 10.1007/s00262-013-1446-2
- By:
- Publication type:
- Article
Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 9, p. 1485, doi. 10.1007/s00262-013-1454-2
- By:
- Publication type:
- Article
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 9, p. 1463, doi. 10.1007/s00262-013-1449-z
- By:
- Publication type:
- Article
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 9, p. 1499, doi. 10.1007/s00262-013-1453-3
- By:
- Publication type:
- Article
Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 9, p. 1521, doi. 10.1007/s00262-013-1448-0
- By:
- Publication type:
- Article
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 9, p. 1475, doi. 10.1007/s00262-013-1452-4
- By:
- Publication type:
- Article